ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 234 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q2 2017. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $458,000 | -23.3% | 35,890 | -23.8% | 0.18% | -7.2% |
| Q1 2017 | $597,000 | +15.0% | 47,092 | +19.5% | 0.19% | +56.5% |
| Q3 2016 | $519,000 | -56.3% | 39,400 | -57.9% | 0.12% | -43.1% |
| Q2 2016 | $1,188,000 | -56.8% | 93,514 | -55.1% | 0.22% | -44.9% |
| Q1 2016 | $2,749,000 | -17.3% | 208,071 | -3.7% | 0.40% | +10.6% |
| Q4 2015 | $3,323,000 | -12.9% | 216,092 | -29.8% | 0.36% | -2.7% |
| Q3 2015 | $3,815,000 | -12.2% | 307,671 | -3.1% | 0.37% | -13.2% |
| Q2 2015 | $4,343,000 | -14.5% | 317,501 | -25.2% | 0.42% | -14.9% |
| Q1 2015 | $5,079,000 | +3016.0% | 424,688 | +3225.1% | 0.50% | +3012.5% |
| Q4 2014 | $163,000 | -87.0% | 12,772 | -86.3% | 0.02% | -85.2% |
| Q3 2014 | $1,250,000 | +2.0% | 93,171 | +22.0% | 0.11% | +12.5% |
| Q2 2014 | $1,226,000 | -47.6% | 76,388 | -57.8% | 0.10% | -2.0% |
| Q2 2013 | $2,341,000 | – | 180,885 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 1,500,000 | $21,593,000 | 4.50% |
| KESTREL INVESTMENT MANAGEMENT CORP | 445,500 | $6,433,000 | 3.14% |
| Adirondack Research & Management Inc. | 155,088 | $2,239,000 | 3.06% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 9,398,617 | $135,716,029,000 | 2.92% |
| Waterfront Wealth Inc. | 136,976 | $1,978,000 | 1.40% |
| Smith, Graham & Co., Investment Advisors, LP | 1,008,283 | $14,560,000 | 1.34% |
| S&T BANK/PA | 475,184 | $6,862,000 | 1.23% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,132,500 | $16,354,000 | 0.98% |
| HENNESSY ADVISORS INC | 1,024,100 | $14,788,000 | 0.95% |
| BEACONLIGHT CAPITAL, LLC | 208,546 | $3,011,000 | 0.91% |